These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 30686644)

  • 1. Quality of Life is Related to Haemodynamics in Precapillary Pulmonary Hypertension.
    Arvanitaki A; Mouratoglou SA; Evangeliou A; Grosomanidis V; Hadjimiltiades S; Skoura L; Feloukidis C; Farmakis D; Karvounis H; Giannakoulas G
    Heart Lung Circ; 2020 Jan; 29(1):142-148. PubMed ID: 30686644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study.
    Berghaus TM; Kutsch J; Faul C; von Scheidt W; Schwaiblmair M
    BMC Pulm Med; 2017 Dec; 17(1):167. PubMed ID: 29202745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of clinical and physiological relations of daily physical activity in precapillary pulmonary hypertension.
    Panagiotou M; Johnson MK; Louvaris Z; Baker JS; Church AC; Peacock AJ; Vogiatzis I
    J Appl Physiol (1985); 2017 Oct; 123(4):851-859. PubMed ID: 28663381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of circulating natriuretic peptides with haemodynamics in precapillary pulmonary hypertension.
    Kaiser R; Grotemeyer K; Lepper P; Stokes C; Bals R; Wilkens H
    Respir Med; 2015 Sep; 109(9):1213-23. PubMed ID: 26194624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of right ventricular longitudinal strain by 2D speckle tracking imaging compared with RV function and hemodynamics in pulmonary hypertension.
    Li Y; Wang Y; Meng X; Zhu W; Lu X
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1737-1748. PubMed ID: 28553693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The longitudinal use of EmPHasis-10 and CAMPHOR questionnaire health-related quality of life scores in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Hendriks PM; van Thor MCJ; Wapenaar M; Chandoesing P; van den Toorn LM; van den Bosch AE; Post MC; Boomars KA
    Respir Med; 2021 Sep; 186():106525. PubMed ID: 34218166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
    Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial Hypertension.
    Chin KM; Rubin LJ; Channick R; Di Scala L; Gaine S; Galiè N; Ghofrani HA; Hoeper MM; Lang IM; McLaughlin VV; Preiss R; Simonneau G; Sitbon O; Tapson VF
    Circulation; 2019 May; 139(21):2440-2450. PubMed ID: 30982349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Right Ventricular Function is Associated With Quality of Life in Patients With Systemic Lupus Erythematosus Associated Pulmonary Arterial Hypertension.
    Wang H; Wang Q; Tian Z; Guo X; Lai J; Li M; Zhao J; Liu Y; Zeng X; Fang Q
    Heart Lung Circ; 2019 Nov; 28(11):1655-1663. PubMed ID: 30301670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exercise dependence of N-terminal pro-brain natriuretic peptide in patients with precapillary pulmonary hypertension.
    Grachtrup S; Brügel M; Pankau H; Halank M; Wirtz H; Seyfarth HJ
    Respiration; 2012; 84(6):454-60. PubMed ID: 22327025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The value of brain natriuretic peptide in connective tissue diseases associated with pulmonary arterial hypertension].
    Tian Z; Guo XX; Li MT; Wang Q; Liu YT; Zhao JL; Fang Q; Zeng XF
    Zhonghua Nei Ke Za Zhi; 2011 Feb; 50(2):102-6. PubMed ID: 21418827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SERAPHIN haemodynamic substudy: the effect of the dual endothelin receptor antagonist macitentan on haemodynamic parameters and NT-proBNP levels and their association with disease progression in patients with pulmonary arterial hypertension.
    Galiè N; Jansa P; Pulido T; Channick RN; Delcroix M; Ghofrani HA; Le Brun FO; Mehta S; Perchenet L; Rubin LJ; Sastry BKS; Simonneau G; Sitbon O; Souza R; Torbicki A
    Eur Heart J; 2017 Apr; 38(15):1147-1155. PubMed ID: 28329315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension.
    Parikh KS; Dahhan T; Nicholl L; Ruopp N; Pomann GM; Fortin T; Tapson VF; Rajagopal S
    Sci Rep; 2019 Mar; 9(1):4061. PubMed ID: 30858405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
    Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
    Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved hemodynamics and cardiopulmonary function in patients with inoperable chronic thromboembolic pulmonary hypertension after balloon pulmonary angioplasty.
    Jin Q; Luo Q; Yang T; Zeng Q; Yu X; Yan L; Zhang Y; Zhao Q; Ma X; An C; Xiong C; Zhao Z; Liu Z
    Respir Res; 2019 Nov; 20(1):250. PubMed ID: 31703589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurohormonal activation in patients with systemic sclerosis-related pulmonary arterial hypertension.
    Dimitroulas T; Giannakoulas G; Karvounis H; Sfetsios T; Koliakos G; Parcharidis G; Settas L
    Int J Cardiol; 2007 Sep; 121(1):135-7. PubMed ID: 17088004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired Blood Rheology in Pulmonary Arterial Hypertension.
    Yaylali YT; Kilic-Toprak E; Ozdemir Y; Senol H; Bor-Kucukatay M
    Heart Lung Circ; 2019 Jul; 28(7):1067-1073. PubMed ID: 30253971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Riociguat for the treatment of pulmonary arterial hypertension.
    Ghofrani HA; Galiè N; Grimminger F; Grünig E; Humbert M; Jing ZC; Keogh AM; Langleben D; Kilama MO; Fritsch A; Neuser D; Rubin LJ;
    N Engl J Med; 2013 Jul; 369(4):330-40. PubMed ID: 23883378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.